Muller Lorenz

Chief Commercial OfficerMilestone Pharmaceuticals Inc. (MIST) · full profile →Form 4 · filed Jan 28, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$146K
Net Open-Market Flow
-$146K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 26, 2026Option exercise(M)20K217K
Jan 26, 2026Sell(S)11K$1.93$22K205K
Dec 15, 2025Sell(S)54K$2.32$124K196K
Dec 12, 2025Grant(A)100K250K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 26, 2026Option exercise(M)20K$060K
Dec 12, 2025Grant(A)100K$0100K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001771207-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly: